July 25, 2025

ADA debuts new informatics standards webpage for easy access, adoption

The ADA is making it easier than ever to access and adopt its informatics standards.

ADA News

July 25, 2025

SmileCon 2025 to offer curated learning experiences for entire team

SmileCon 2025 will equip dentists and their teams with skills and strategies to thrive in an evolving industry.

ADA News

July 25, 2025

Spontaneous Urticaria Carries Greater Burden, Costs

Researchers assess how disease type, comorbidities, and treatment knowledge shape clinical outcomes and healthcare use in patients with chronic urticaria.

Conexiant

July 24, 2025

Penicillin Allergy Label? Or Antibiotic Overuse?

Structured testing in primary care boosted penicillin prescribing fivefold, lowered overall antibiotic use, and proved cost-effective.

Conexiant

July 24, 2025

Maternal RSV Vaccine Shows 72% Effectiveness

Following national rollout, UK data provide early post-licensure evidence supporting maternal RSV vaccination as a real-world strategy to lower infant hospital admissions.

Conexiant

July 23, 2025

ADA urges DEA to ease registration rules for dentists with multiple practice locations

The ADA urged the DEA to revise a rule requiring separate registrations for each location a practitioner prescribes controlled substances.

ADA News

July 23, 2025

Rethinking Uveitis

How might uveitis treatment be reconsidered in light of new evidence?

The Ophthalmologist

July 23, 2025

IDSA Issues Stratified Antibiotic Approach for complicated UTIs

New recommendations outline a stratified antibiotic treatment for complicated urinary tract infections, including shorter durations, oral transition timing, and tailored empiric choices based on illness severity and resistance risks.

Conexiant

July 21, 2025

Resistance to Bedaquiline Impacts TB Survival

A cohort study found that patients with bedaquiline-resistant tuberculosis had delayed microbiologic recovery, higher rates of treatment failure, and reduced tuberculosis-free survival at 18 months compared with those with bedaquiline-susceptible disease.

Conexiant